Project Grant HT94252510461
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$715K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $292,260 project grant to the Henry Ford Health System in Detroit, Michigan. The grant, with a period of performance from July 1, 2025 to June 30, 2028, will support research to find the missing link between pancreatic neoplasia and carcinoma. As a non-profit integrated healthcare provider and research organization, the Henry Ford Health System will...
The Defense Health Agency awarded a $523,663 Project Grant to the Henry Ford Health System - doing business as Henry Ford Hospital, a non-profit hospital in Detroit, Michigan. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate the NETRIN G1 ligand as a new immunomodulatory target and early biomarker in pancreatic cancer. The project will be conducted from August 1, 2023 to July 31, 2026. Henry Ford Health System has...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $532,000.00 in funding to the Henry Ford Health System in Detroit, MI. The grant supports research to investigate HDAC3 as a potential therapeutic target for Langerhans cell histiocytosis, a rare medical condition. The performance period for this grant runs from December 1, 2024 to November 30, 2027. As a prominent non-profit...
This $911,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by the Henry Ford Health System in Detroit, Michigan to target mitochondrial metabolism in ovarian cancer. The award, effective April 1, 2024 through March 31, 2028, will support basic, translational, and clinical research aimed at developing new treatments, diagnostic tools, and preventive measures for this area of military medical importance....
The Henry Ford Health System was awarded a $615,782 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 15, 2022 to July 14, 2025 to investigate paracrine pathways contributing to the growth and invasion of neurofibromas and the role of the cellular microenvironment. Through this research, the awardee aims to advance understanding of medical solutions for neurofibromas,...
The federal Project Grant award, valued at $728,450.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research conducted by the Cold Spring Harbor Laboratory (CSHL) on the communication between cancer-associated fibroblasts and neurons, and how this interaction promotes the progression of pancreatic cancer. The award, which runs from July 1, 2025 to June 30, 2028, will enable CSHL to carry out advanced biomedical...
This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
The federal Project Grant award, ID HT94252410512, in the amount of $1,008,313.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
This $729,690 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports metabolic intervention research to halt pancreatic cancer at Cedars-Sinai Medical Center in West Hollywood, California. The project will run from November 1, 2024 to October 31, 2027, investigating innovative approaches to disease prevention, diagnosis, treatment, and management of pancreatic cancer. As a prominent research institution,...